Diffuse Large B-Cell Lymphoma in the Older and Frail Patient
Cancers · 05.03.2025 · 17 (5) · 885
DOI: 10.3390/cancers17050885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 05.03.2025. Verfasst von Emily C Ayers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Outcomes in older, unfit, and frail patients with diffuse large B-cell lymphoma (DLBCL) are inferior compared to younger and fit patients. Despite tremendous progress in the treatment landscape of DLBCL, few clinical trials have focused specifically on this high-risk patient population. This review focuses on the pathophysiology unique to the older patient with DLBCL, as well as the evidence behind current treatment approaches. This article also aims to highlight emerging prognostic tools and novel treatment strategies that may improve the outcomes in this patient cohort in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
- Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
ORCID-Profile: Emily C Ayers
Zitieren
APA
Ayers, E. C., & Smith, S. M. (2025). Diffuse Large B-Cell Lymphoma in the Older and Frail Patient. Cancers, 17(5), 885. https://doi.org/10.3390/cancers17050885
Vancouver
Ayers EC, Smith SM. Diffuse Large B-Cell Lymphoma in the Older and Frail Patient. Cancers. 2025;17(5):885. doi:10.3390/cancers17050885
BibTeX
@article{Ayers2025,
author = {Ayers, Emily C and Smith, Sonali M},
title = {Diffuse Large B-Cell Lymphoma in the Older and Frail Patient},
journal = {Cancers},
year = {2025},
volume = {17},
number = {5},
pages = {885},
doi = {10.3390/cancers17050885}
}
EUVIMED